Advance Care Planning: A Convincing Argument to Make It Part of Liver Transplant Evaluation
Manisha Verma, Tamar Taddei, Michael Volk, Victor Navarro – 25 September 2020
Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis
John E. Eaton, Christopher L. Welle, Zeinab Bakhshi, Shannon P. Sheedy, Ilkay S. Idilman, Gregory J. Gores, Charles B. Rosen, Julie K. Heimbach, Timucin Taner, Denise M. Harnois, Keith D. Lindor, Nicholas F. LaRusso, Andrea A. Gossard, Konstantinos N. Lazaridis, Sudhakar K. Venkatesh – 25 September 2020
Correction
24 September 2020
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease
Simon Lam, Ruchi Singh, Jonathan R. Dillman, Andrew T. Trout, Suraj D. Serai, Divya Sharma, Rachel Sheridan, Weizhe Su, Lin Fei, Rebekah Karns, Marija M. Haramija, Ged Ridgway, Marc Goldfinger, James E. Squires, Lee A. Denson, Jeffery S. Hyams, Alexander G. Miethke – 24 September 2020 – In autoimmune liver disease (AILD), including autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), and overlap syndrome of AIH and PSC (ASC), the presence of biliary injury portends a worse prognosis.
Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma
Vincent L. Chen, Ming‐Lun Yeh, Ju Dong Yang, Jennifer Leong, Daniel Q. Huang, Hidenori Toyoda, Yao‐Li Chen, Jennifer Guy, Mayumi Maeda, Pei‐Chien Tsai, Chung‐Feng Huang, Satoshi Yasuda, An K. Le, Hansen Dang, Nasra H. Giama, Hamdi A. Ali, Ning Zhang, Xiaozhong Wang, Dae Won Jun, Cheng‐Hao Tseng, Yao‐Chun Hsu, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Qiang Zhu, Yock Young Dan, Myron Schwartz, Lewis R. Roberts, Ming‐Lung Yu, Mindie H.
LiverLearning®: 2020 Transplant Hepatology Board Review Course
The 2020 AASLD Transplant Hepatology Board Review Course set for August 15-16 in Dallas, TX is now an on-demand course. This on-demand course will release on Friday, August 15, 2020. For further questions contact education@aasld.org. This course will help prepare physicians for the American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP) certification and maintenance of certification (MOC) exam in transplant hepatology and pediatric transplant hepatology as it reflects the updated ABIM/ABP Transplant Hepatology Certification Exam blueprint.
Activating Adenosine Monophosphate–Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice
Qian Lin, Zhifeng Huang, Genxiang Cai, Xia Fan, Xiaoqing Yan, Zhengshuai Liu, Zehua Zhao, Jingya Li, Jia Li, Hongxue Shi, Maiying Kong, Ming‐Hua Zheng, Daniel J. Conklin, Paul N. Epstein, Kupper A. Wintergerst, Moosa Mohammadi, Lu Cai, Xiaokun Li, Yu Li, Yi Tan – 23 September 2020
Hepatocyte Mitogen‐Activated Protein Kinase Kinase 7 Contributes to Restoration of the Liver Parenchyma Following Injury in Mice
Takako Ooshio, Masahiro Yamamoto, Kiyonaga Fujii, Bing Xin, Kenji Watanabe, Masanori Goto, Yoko Okada, Akira Suzuki, Josef M. Penninger, Hiroshi Nishina, Yuji Nishikawa – 23 September 2020
Letter to the Editor: Statin Reduces the Risk of Hepatocellular Carcinoma Development in Patients With CHB
Bo‐Han Zhang, Yun‐Shi Cai, Jiu‐Lin Song, Tao Lyu, Jian Yang, Li Jiang, Jia‐Yin Yang – 23 September 2020
Letter to the Editor: Nonalcoholic Fatty Liver Disease—One Size May Not Fit All
Aze Wilson, Melanie Beaton, Mayur Brahmania – 23 September 2020